A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir - Plank, J; Bodenlenz, M; Sinner, F; Magnes, C; Görzer, E; Regittnig, W; Endahl, L A; Draeger, E; Zdravkovic, M; Pieber, T R (Diabetes Care, 2005)